News

If you've got $1,000 to invest, I think two stocks trading right around $200 a share look quite attractive. With that amount of money, you'd be able to buy five shares of one stock or split it up

Nvidia (NASDAQ: NVDA) and Advanced Micro Devices (NASDAQ: AMD) have been among the leading providers of the specialized processors used for artificial intelligence. These graphics processing units

Nvidia (NASDAQ:NVDA), which develops GPUs and AI hardware/software solutions, closed Thursday at $183.34, up 0.16%. The stock’s modest gain follows as overnight coverage highlights bullish 2026

Considering that most companies don't even stay in business for 20 years, finding stocks worth holding onto for good isn't always easy. Thankfully, some seem to have the qualities that will enable

Oncology is the largest therapeutic area in the biopharma industry, in terms of sales. The rapid rise in recent years of drugs to treat diabetes and manage weight loss might disrupt the traditional

Shares of Evolus (NASDAQ: EOLS) climbed on Wednesday after the aesthetics specialist announced that it achieved profitability.

By the close of trading, Evolus' stock price was up over 35%.

Image

Orion Group Holdings (NYSE: ORN) stock, the maritime construction company, tumbled nearly 9% in early trading Wednesday before reversing to gain more than 4%... before reversing again and giving

Change is exciting, and it comes with risks. This is why turnaround stocks are so interesting. Right now, Teva Pharmaceutical Industries (NYSE: TEVA) is a turnaround story that may appeal to

Gene editing, a set of techniques used to alter sections of an organism's DNA, is helping scientists cure diseases previously considered untreatable. That's why biotechs that specialize in gene

Many investors have adopted a passive investing approach that incorporates heavy allocations to exchange-traded funds. By using ETFs, investors can easily build a portfolio that has a ton of diversi

There were times when investors may have worried about hanging onto AbbVie (NYSE: ABBV) stock.

A decade ago, more than 63% of the pharmaceutical giant's revenue was tied up in one drug -- Humira

Eli Lilly's (NYSE: LLY) big problem is its success in the GLP-1 drug space. Its Mounjaro (for diabetes) and Zepbound (for weight loss) drugs grew sales by 99% and 175%, respectively, in 2025.

That's

Blue chip dividend stocks are usually stable long-term investments, but they lost their luster in 2022 and 2023 as rising interest rates made CDs and T-bills more attractive. However, the Federal

You've heard a lot about how stocks can help make you rich. But what if you don't have the time to spend digging through hundreds or even thousands of different companies looking for the ones that

Broader equities have been relatively volatile over the past few months. In an environment like this, it's best to prioritize investing in well-established, profitable corporations. While small-cap

Cathie Wood seems to always be making market moves. The founder and CEO of Ark Invest publishes her transactions at the end of every trading day, and that gives us all a great way to track one of

If you ask me for a reason I'd buy Pfizer (NYSE: PFE) stock and never sell it, I certainly have one -- because I've already bought into Pfizer, and I have no plans to sell it. Here's a look at why I

For years, UnitedHealth Group (NYSE: UNH) stock has been a terrific growth investment. In fact, it looked unstoppable. Not only did it repeatedly grow its dividend, but the stock was amassing some

Dividend stocks can make for great long-term investments. They can generate a steady stream of income for your portfolio, not only padding your overall returns but also providing you with a way to

Matthew Strobeck, a Board Director at QuidelOrtho Corp. (NASDAQ:QDEL), reported the purchase of 10,000 common shares on Feb. 13, 2026, for a total transaction value of ~$240,000, as disclosed in a

On Feb. 24, 2026, Ardelyx (NASDAQ:ARDX) President and CEO Michael Raab reported the sale of 41,666 shares of Common Stock for approximately $261,000, according to a SEC Form 4 filing.

Transaction

The four largest hyperscalers (owners of large data centers) have said they have plans to spend more than $650 billion this year building out their artificial intelligence (AI) infrastructure. Let's

Investing in individual stocks can make you rich. But in stark contrast to many of the promotional materials you'll see just about everywhere on the internet, stock investing isn't always easy. For

Regencell Bioscience (NASDAQ: RGC), a China-based drugmaker, has been on fire over the past 12 months, with its share price skyrocketing by more than 21,000% as of this writing (that's not a typo)